Exploring Medication Effectiveness Using Machine Learning: A Multiclass Treatment Outcome Analysis

Additional Authors

Avas Bajracharya, Ghaith Husari

Abstract

Understanding how medication influences patient treatment outcomes is critical for improving healthcare decision-making. According to the Centers for Disease Control and Prevention (CDC, 2024), medicines are safe when used as prescribed; however, adverse drug events occur when medications cause harm, including side effects or medication errors. Medication errors harm at least 1.5 million people annually and cost approximately $3.5 billion each year in hospital-related expenses alone (Institute of Medicine, 2007). While clinicians rely on medical expertise, a significant gap exists in using automated data-driven approaches to reveal subtle medication patterns that are not immediately apparent in traditional analysis. This study examines whether medication-related features, including drug type, treatment duration, dosage, and reported side effects, can classify patient improvement levels using machine learning techniques. We hypothesized that medication-level data would significantly predict patient improvement outcomes. The dataset was cleaned, encoded, and split into training and testing sets, and the improvement score was categorized into three levels: Low, Medium, and High. Multiple supervised learning models, including Random Forest, Decision Tree, Logistic Regression, Support Vector Machine (SVM), Gradient Boosting, and AdaBoost—were trained and evaluated using accuracy and F1-weighted metrics. Results indicate moderate predictive performance, with the best-performing model achieving 48.33% accuracy. Although predictive accuracy was modest, findings suggest that medication-level data contain meaningful patterns associated with treatment improvement. The study highlights the complexity of healthcare outcomes and suggests that incorporating richer clinical and patient-specific variables may enhance predictive performance. Overall, this research demonstrates the potential of machine learning as a supportive tool for healthcare analytics and informed treatment decision-making.

Start Time

15-4-2026 1:30 PM

End Time

15-4-2026 4:30 PM

Room Number

Culp Ballroom 316

Presentation Type

Poster

Student Type

Graduate and Professional Degree Students, Residents, Fellows

Faculty Mentor

Ghaith Husari

This document is currently not available here.

Share

COinS
 
Apr 15th, 1:30 PM Apr 15th, 4:30 PM

Exploring Medication Effectiveness Using Machine Learning: A Multiclass Treatment Outcome Analysis

Culp Ballroom 316

Understanding how medication influences patient treatment outcomes is critical for improving healthcare decision-making. According to the Centers for Disease Control and Prevention (CDC, 2024), medicines are safe when used as prescribed; however, adverse drug events occur when medications cause harm, including side effects or medication errors. Medication errors harm at least 1.5 million people annually and cost approximately $3.5 billion each year in hospital-related expenses alone (Institute of Medicine, 2007). While clinicians rely on medical expertise, a significant gap exists in using automated data-driven approaches to reveal subtle medication patterns that are not immediately apparent in traditional analysis. This study examines whether medication-related features, including drug type, treatment duration, dosage, and reported side effects, can classify patient improvement levels using machine learning techniques. We hypothesized that medication-level data would significantly predict patient improvement outcomes. The dataset was cleaned, encoded, and split into training and testing sets, and the improvement score was categorized into three levels: Low, Medium, and High. Multiple supervised learning models, including Random Forest, Decision Tree, Logistic Regression, Support Vector Machine (SVM), Gradient Boosting, and AdaBoost—were trained and evaluated using accuracy and F1-weighted metrics. Results indicate moderate predictive performance, with the best-performing model achieving 48.33% accuracy. Although predictive accuracy was modest, findings suggest that medication-level data contain meaningful patterns associated with treatment improvement. The study highlights the complexity of healthcare outcomes and suggests that incorporating richer clinical and patient-specific variables may enhance predictive performance. Overall, this research demonstrates the potential of machine learning as a supportive tool for healthcare analytics and informed treatment decision-making.